$ESI

Here Are Friday’s Top Wall Street Analyst Research Calls: Atmos Energy, Celanese, Check Point Software, Chewy, Dell Technologies, Fortinet, Global Payments, HP, Shopify, and More

Major indices closed lower Thursday, with the Russell 2000 down 1.04%. Brent Crude surged 7.2% to $108.60 due to U.S.-Iran tensions. Morgan Stanley downgraded Novo Nordisk (NVO) to Underweight, while RBC initiated Dell (DELL) with an Outperform rating and $640 target. Analysts also made calls on Atmos Energy (ATO), Celanese (CE), Check Point (CHKP), Chewy (CHWY), Fortinet (FTNT), Global Payments (GPN), HP (HPQ), and Shopify (SHOP).

Original reporting
Published Sep 11, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here Are Friday’s Top Wall Street Analyst Research Calls: Atmos Energy, Celanese, Check Point Software, Chewy, Dell Technologies, Fortinet, Global Payments, HP, Shopify, and More — source image
Decision brief

The 30-second read

$ESIBullishLow
01

Why it matters

While the individual rating changes provide modest directional cues, the overall market impact is limited to short‑term price adjustments.

02

Market read

A typical analyst rating roundup with modest trading relevance; useful for short‑term positioning on specific tickers.

03

What to watch

Potential hidden catalysts such as upcoming earnings or sector-specific news not covered in the upgrade/downgrade list.

Relevance 5/10Novelty 4/10Timing: Friday

Background

The article aggregates recent analyst upgrades, downgrades, and initiations across multiple U.S.-listed stocks.

Company-level read

Ticker impact

$ESIBullishMedium confidence
Context

Element Solutions was reinstated with a Buy rating at Goldman Sachs with a $44 target price.

Expected impact

potential upside of 5‑10% over the next weeks

Evidence & confidence

Upgrade from neutral with a modest target suggests limited upside.

$IPBullishMedium confidence
Context

International Paper upgraded to Buy from Neutral at Bank of America, target cut to $46.

Expected impact

possible 3‑6% gain in the short term

Evidence & confidence

Upgrade signals improved outlook despite lower target price.

$ATOBearishMedium confidence
Context

Atmos Energy downgraded to Neutral from Overweight at JPMorgan, target cut to $180.

Expected impact

potential 2‑5% decline in the near term

Evidence & confidence

Neutral rating and lower target suggest weaker expectations.

$CHKPBearishMedium confidence
Context

Check Point Software downgraded to Neutral from Outperform at Wedbush, target cut to $135.

Expected impact

possible 3‑7% drop shortly after release

Evidence & confidence

Target reduction and rating downgrade indicate reduced confidence.

$CHWYBearishMedium confidence
Context

Chewy downgraded to Neutral from Overweight at JPMorgan, target trimmed to $24.

Expected impact

expected 2‑4% pullback

Evidence & confidence

Lower target and neutral stance suggest weaker outlook.

$FTNTNeutralLow confidence
Context

Fortinet downgraded to Neutral from Outperform at Wedbush, target raised to $155.

Expected impact

limited movement, likely within ±2%

Evidence & confidence

Target increase offsets rating downgrade, creating uncertainty.

$NVOBearishMedium confidence
Context

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley, target unchanged at $40.

Expected impact

potential 3‑6% decline

Evidence & confidence

Underweight suggests weaker relative performance expectations.

$CEBullishMedium confidence
Context

Celanese initiated with an Overweight rating at Keybanc, target $57.

Expected impact

possible 4‑8% upside

Evidence & confidence

Initiation at Overweight signals strong confidence from analyst.

Market effects

Broad analyst activity may slightly shift sentiment in utilities, tech, and consumer discretionary sectors.

U.S. market sentiment modestly affected; no major regional ripple.

Limited global impact; primarily U.S. equity focus.

Counterpoint

Some investors may view the downgrades as overreactions and look for buying opportunities on the dip.

Key entities

  • Morgan Stanley

    Provided downgrade on Novo Nordisk.

  • RBC Capital

    Initiated Dell, HP and other stocks.

Related articles

$DELLMedAI 8/10

Dell Booked More AI Server Orders in 3 Months Than It Recorded in Total Revenue

Dell Technologies (DELL) shares rose 12% after reporting strong fiscal Q2 2027 results. AI server orders reached $60.9B, exceeding total revenue of $47B. Revenue grew 58% YoY, and non-GAAP EPS tripled to $7.04. Dell raised full-year revenue guidance to $192B and AI server revenue to $74B. Operating cash flow declined to $2.2B, but adjusted free cash flow increased 224% YoY to $8.1B.

$DELLHighAI 8/10

Dell stock hits all-time high on RBC Capital outperform rating

Dell's stock rose 10% to an all-time high after RBC Capital initiated coverage with an outperform rating and a $640 price target. The analyst cited Dell's $95B server backlog, $16.4B in AI server sales, and strong supply chain. Dell's Q2 results exceeded expectations, with 89% YoY growth in Infrastructure Solutions Group revenue. The company raised its full-year revenue outlook to $192B and EPS guidance to $25.50.

$NVOMed

Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test

Novo Nordisk (NVO) reported positive results from the STEP Young trial, showing 40.4% of children treated with semaglutide (Wegovy's active ingredient) were no longer classified as obese after 68 weeks. This could expand Wegovy's market, but regulatory approval and adoption remain key uncertainties. NVO faces pressure to find new growth drivers after a setback in the REDEFINE 4 trial.

$DELLLow

Dell Technologies Sees AI Boom Building as $95B Server Backlog Signals Demand

Dell Technologies reports a $95 billion AI server backlog, following $130 billion in orders over the past year, indicating strong demand. CEO Michael Dell highlights early-stage enterprise AI adoption, with 6,500 AI Factory customers. Dell expects long-term growth in servers, storage, networking, and PCs driven by AI, sovereign projects, and aging hardware. Supply constraints and higher memory costs may impact demand through 2027.

$NVOMedAI 8/10

What Do We Actually Know About Kids on Weight-Loss Drugs?

GLP-1 drugs like semaglutide (Novo Nordisk) and tirzepatide (Eli Lilly) are increasingly prescribed off-label for obesity in children. A study found 0.6% of children ages 8-11 were prescribed GLP-1s between 2019-2026, with usage rising yearly. Novo Nordisk's trial showed 40% of children aged 6-12 were no longer obese after 68 weeks of semaglutide treatment. Approval for younger age groups is pending.

$DELLMedAI 8/10

Jim Cramer Compares Dell (DELL) to Dallas Cowboys Star CeeDee Lamb

Jim Cramer compared Dell Technologies (NYSE:DELL) to Dallas Cowboys' CeeDee Lamb, citing its strong AI demand and stock performance. Dell reported record Q2 2027 revenue of $47B, up 58% YoY, driven by AI server sales. The company raised its full-year revenue outlook to $192B. However, supply chain constraints pose risks. Hedge fund ownership increased to 77 in Q2, with short interest at 4.64%.